Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Remote monitoring of patients with rheumatoid arthritis: a mixed methods evaluation across six hospitals in London, UK.
Watson K, Sheldon H, Pallari E, Arumalla N, Olive RR, Boiko O, Aznar C, Adams EJ, Bosworth A, Demetriou L, Martin M, Palmer MA, Sinclair P, Smith EJ, Sevdalis N, Walker A, Garrood T. Watson K, et al. Among authors: garrood t. Rheumatology (Oxford). 2024 Feb 24:keae112. doi: 10.1093/rheumatology/keae112. Online ahead of print. Rheumatology (Oxford). 2024. PMID: 38402509
Abatacept in individuals at high risk of rheumatoid arthritis (APIPPRA): a randomised, double-blind, multicentre, parallel, placebo-controlled, phase 2b clinical trial.
Cope AP, Jasenecova M, Vasconcelos JC, Filer A, Raza K, Qureshi S, D'Agostino MA, McInnes IB, Isaacs JD, Pratt AG, Fisher BA, Buckley CD, Emery P, Ho P, Buch MH, Ciurtin C, van Schaardenburg D, Huizinga T, Toes R, Georgiou E, Kelly J, Murphy C, Prevost AT; APIPPRA study investigators. Cope AP, et al. Lancet. 2024 Mar 2;403(10429):838-849. doi: 10.1016/S0140-6736(23)02649-1. Epub 2024 Feb 13. Lancet. 2024. PMID: 38364839 Free article. Clinical Trial.
Upadacitinib response rates in patients with psoriatic arthritis enrolled in the SELECT-PsA-1 and SELECT-PsA-2 trials assessed according to modified PsARC.
Coates LC, Garrood T, Gullick N, Helliwell P, Kent T, Marks J, Tillett W, Kaur-Papadakis D, Tahir H, van Haaren S, McInnes I. Coates LC, et al. Among authors: garrood t. Rheumatology (Oxford). 2022 Dec 23;62(1):e1-e3. doi: 10.1093/rheumatology/keac388. Rheumatology (Oxford). 2022. PMID: 35799375 Free article. No abstract available.
Correction to: Persistent physical symptoms reduction intervention: a system change and evaluation in secondary care (PRINCE secondary) - a CBT-based transdiagnostic approach: study protocol for a randomised controlled trial.
Chalder T, Patel M, James K, Hotopf M, Frank P, Watts K, McCrone P, David A, Ashworth M, Husain M, Garrood T, Moss-Morris R, Landau S. Chalder T, et al. Among authors: garrood t. BMC Psychiatry. 2020 Aug 12;20(1):403. doi: 10.1186/s12888-020-02811-w. BMC Psychiatry. 2020. PMID: 32787819 Free PMC article.
Imaging neoangiogenesis in rheumatoid arthritis (INIRA): whole-body synovial uptake of a 99mTc-labelled RGD peptide is highly correlated with power Doppler ultrasound.
Attipoe L, Chaabo K, Wajed J, Hassan FU, Shivapatham D, Morrison M, Ballinger J, Cook G, Cope AP, Garrood T. Attipoe L, et al. Among authors: garrood t. Ann Rheum Dis. 2020 Sep;79(9):1254-1255. doi: 10.1136/annrheumdis-2020-217228. Epub 2020 Apr 23. Ann Rheum Dis. 2020. PMID: 32327424 No abstract available.
Persistent physical symptoms reduction intervention: a system change and evaluation in secondary care (PRINCE secondary) - a CBT-based transdiagnostic approach: study protocol for a randomised controlled trial.
Chalder T, Patel M, James K, Hotopf M, Frank P, Watts K, McCrone P, David A, Ashworth M, Husain M, Garrood T, Moss-Morris R, Landau S. Chalder T, et al. Among authors: garrood t. BMC Psychiatry. 2019 Oct 22;19(1):307. doi: 10.1186/s12888-019-2297-y. BMC Psychiatry. 2019. PMID: 31640632 Free PMC article.
32 results